Monitoring of minimal residual disease (MRD) in chronic myeloid leukemia: recent advances

C Cumbo, L Anelli, G Specchia… - Cancer management and …, 2020 - Taylor & Francis
… (9;22)(q34;q11) rearrangement. The identification of the BCR-… to have evidence of persistent
leukemic cells by DNA PCR. … residual CML LSC may be transcriptionally silent and so not …

[HTML][HTML] Mechanisms of disease progression and resistance to tyrosine kinase inhibitor therapy in chronic myeloid leukemia: an update

L Bavaro, M Martelli, M Cavo, S Soverini - International journal of …, 2019 - mdpi.com
… -independent resistance and leukemia stem cell persistence. … ), to increase the transcriptional
activity perturbing the JAK-… from intra-or inter-chromosomal rearrangements and mostly …

An integrative model of pathway convergence in genetically heterogeneous blast crisis chronic myeloid leukemia

TK Ko, A Javed, KL Lee, TN Pathiraja… - Blood, The Journal …, 2020 - ashpublications.org
… were affected by immunoglobulin rearrangements, whereas rearrangements or deletions in
… PRC-related transcriptional signatures We next characterized the transcriptional changes …

Mutational landscape of chronic myeloid leukemia: more than a single oncogene leukemia

S Adnan-Awad, M Kankainen, S Mustjoki - Leukemia & lymphoma, 2021 - Taylor & Francis
… (TKI) that target the BCR-ABL oncoprotein has led to dramatic … These mechanisms contribute
to the persistence of CML LSCs … The study identified distinct phenotypic and transcriptional

[HTML][HTML] Late relapse of chronic myeloid leukemia after allogeneic bone marrow transplantation points to KANSARL (KANSL1:: ARL17A) alteration: a case report with …

D Fontana, GPM Zambrotta, A Scannella, R Piazza… - Annals of …, 2024 - Springer
Chronic myeloid leukemia is a myeloproliferative neoplasm characterized by the presence
of the Philadelphia chromosome and the consequent BCR:: ABL1 oncoprotein. In the era …

[PDF][PDF] Screening and Characterisation of BCR:: ABL1 Kinase Domain Mutations in Chronic Myeloid Leukaemia Participants at Tygerberg Hospital, South Africa

I Shareefa - 2023 - scholar.sun.ac.za
BCR- ABL protein (Figure 1.2). Fifty-five percent (55%) of the b3-a2 transcript and 40% of
the b2- a2 transcript junctions are associated with the 210 kDa BCR::ABL … of rearrangement, …

Using measurable residual disease to optimize management of AML, ALL, and chronic myeloid leukemia

SE Dekker, D Rea, JM Cayuela, I Arnhardt… - American Society of …, 2023 - ascopubs.org
… MRD is defined as the persistence of leukemic cells after … in B-ALL and T-cell receptor gene
rearrangements in T-ALL, and … whether MRD detected by BCR-ABL qPCR or NGS should …

SOHO State of the Art Updates and Next Questions| Update on Treatment-Free Remission in Chronic Myeloid Leukemia (CML)

S Mikhaeel, E Atallah - Clinical Lymphoma Myeloma and Leukemia, 2023 - Elsevier
… This joint pain can be severe and persistent to the point that a small … The existence of this
transcriptionally silent mRNA can … Another possible explanation for BCR::ABL1 persistence

Epigenetic mechanisms underlying the therapeutic effects of HDAC inhibitors in chronic myeloid leukemia

M Lernoux, M Schnekenburger, M Dicato… - Biochemical …, 2020 - Elsevier
… caused by the oncogenic BCR-ABL fusion protein in more … The final product of this genetic
rearrangement is a 210-kDa … transcriptional activity, decreased adherence of leukemia cells to …

The Biology and Pathogenesis of Chronic Myeloid Leukaemia

N Shanmuganathan, B Chereda, JV Melo - Chronic Myeloid Leukemia, 2021 - Springer
Persistence of the LSCs have been postulated to be the … drive expression of their downstream
transcriptional targets [105]. … -associated rearrangements’, involving gene rearrangements